Dentapen® vs. Traditional Syringes for Child Dental Anxiety
Child Anxiety During Administration of Anesthesia Delivered by Dentapen® Technique Versus Traditional Syringes Among a Group of Pediatric Dental Patients: Randomized Clinical Trial
1 other identifier
interventional
42
0 countries
N/A
Brief Summary
This study aims to compare two different methods of giving local anesthesia (numbing medicine) to children during dental treatment. The two methods are: Dentapen® - a computer-controlled, pen-like device that delivers the numbing medicine slowly and steadily. Traditional syringe - the standard metal syringe commonly used in dental clinics. The main question is: Does using the Dentapen® device reduce child anxiety during the injection compared to the traditional syringe? The study will include children aged 6-8 years who need to have an upper primary (baby) molar tooth extracted. The child's heart rate will be measured before and after the injection, and the child's anxiety level will be assessed immediately after treatment using the Wong-Baker Faces Scale (a picture scale showing different levels of worry or fear). Participants will be randomly assigned (like flipping a coin) to receive the injection either with the Dentapen® or with the traditional syringe. Neither the child nor the person measuring the outcomes will know which device was used. The dentist giving the injection cannot be blinded because the devices look different.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2026
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 21, 2026
CompletedFirst Posted
Study publicly available on registry
April 29, 2026
CompletedStudy Start
First participant enrolled
September 22, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
November 23, 2026
Study Completion
Last participant's last visit for all outcomes
December 14, 2026
May 5, 2026
April 1, 2026
2 months
April 21, 2026
April 29, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Child Anxiety
Child anxiety assessed immediately after anesthetic injection and tooth extraction using the Wong-Baker Faces Scale (WBFS). The scale consists of six faces representing increasing levels of anxiety from 0 (no anxiety) to 10 (highest anxiety).
Immediately after treatment (within 5 minutes of completing anesthetic injection and extraction)
Secondary Outcomes (1)
Heart Rate
Baseline (immediately before anesthetic injection) and immediately after completion of anesthetic injection
Study Arms (2)
Dentapen® Technique
EXPERIMENTALChildren in this arm receive local anesthesia using the Dentapen® (Septodont, France), a cordless computer-controlled local anesthetic delivery (CCLAD) system. The ramp-up mode is used to gradually initiate anesthetic flow. Anesthetic solution: 4% articaine with 1:100,000 epinephrine (Artpharma, Egypt) in a 1.7 mL cartridge. A 30-gauge, 20 mm short needle is used. Technique: buccal infiltration followed by intrapapillary infiltration into mesial and distal papillae. Heart rate is measured before and after injection using a pulse oximeter. Child anxiety is assessed immediately post-treatment using the Wong-Baker Faces Scale (WBFS). After confirming anesthesia (subjective patient report and objective dental probe testing), the maxillary primary molar is extracted with minimal trauma using luxation.
Traditional Syringe
ACTIVE COMPARATORChildren in this arm receive local anesthesia using a conventional side-loading stainless steel aspirating syringe (Medesy® 4957/1, Italy). Anesthetic solution: 4% articaine with 1:100,000 epinephrine (Artpharma, Egypt) in a 1.7 mL cartridge. A 30-gauge, 20 mm short, side-beveled, sterile disposable needle is attached. Technique: buccal infiltration (needle bevel oriented toward bone, aspiration performed, solution deposited slowly over one minute) followed by intrapapillary infiltration (needle inserted 1-2 mm into mesial and distal papillae, solution injected slowly over one minute). Heart rate is measured before and after injection using a pulse oximeter. Child anxiety is assessed immediately post-treatment using the Wong-Baker Faces Scale (WBFS). After confirming anesthesia (subjective patient report and objective dental probe testing), the maxillary primary molar is extracted with minimal trauma using luxation.
Interventions
Cordless computer-controlled local anesthetic delivery (CCLAD) system (Septodont, Saint-Maur-des-Fossés, France). Uses ramp-up mode: slowest speed (1 mL/90 s) at maximum force with gradual flow over 5 seconds. Compatible with standard 1.7 mL anesthetic cartridges (4% articaine with 1:100,000 epinephrine) and disposable 30-gauge, 20 mm needles. Delivers buccal and intrapapillary infiltration for maxillary primary molar extraction.
Conventional side-loading stainless steel aspirating syringe (Medesy® 4957/1, Italy). Requires manual control of flow rate and pressure by the operator. Uses standard 1.7 mL anesthetic cartridges (4% articaine with 1:100,000 epinephrine) and disposable 30-gauge, 20 mm side-beveled needles. Delivers buccal and intrapapillary infiltration for maxillary primary molar extraction.
Eligibility Criteria
You may qualify if:
- Children aged between 6 and 8 years.
- Cooperative children.
- Children having normal intellectual development.
- Children willing to provide assent and parent willing to provide informed consent.
- Healthy children with no systemic problems according to parental history.
- First dental visit.
- Children with bilaterally maxillary primary molars indicated for extraction.
You may not qualify if:
- Children with medical, physical, or mental conditions.
- Children requiring emergency dental treatment (cellulitis, abscess).
- Children whose parents refuse to sign the informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Participants were positioned supine with eyes closed during injection to prevent visualization of the device. Outcome assessors evaluated recorded videos where the injection site and the operator's hand holding the device were cropped. The statistician was also blinded to group allocation.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Master degree candidate at Pediatric dentistry department, Faculty of dentistry, Cairo University
Study Record Dates
First Submitted
April 21, 2026
First Posted
April 29, 2026
Study Start (Estimated)
September 22, 2026
Primary Completion (Estimated)
November 23, 2026
Study Completion (Estimated)
December 14, 2026
Last Updated
May 5, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share